Sagimet Biosciences (SGMT) Shares Outstanding (2022 - 2026)

Sagimet Biosciences' Shares Outstanding (Entity) history runs 4 years deep, the most recent figure standing at $32.6 million for Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 1.13% year-over-year to $32.6 million in Q1 2026; TTM through Mar 2026 was $32.6 million, a 1.13% increase from a year earlier, with the FY2025 full-year figure at $32.3 million, up 3.17% from the prior year.
• Shares Outstanding (Entity) rose to $32.6 million in Q1 2026 per SGMT's latest filing, from $32.3 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $32.6 million in Q1 2026 and bottomed at $10.5 million in Q4 2023.
• The 4-year median for Shares Outstanding (Entity) is $31.4 million (2024), against an average of $28.5 million.
• Across the five-year window, Shares Outstanding (Entity) surged 199.71% in 2024 and increased 1.13% in 2026, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $10.5 million in 2023, then jumped by 199.71% to $31.4 million in 2024, then increased by 3.17% to $32.3 million in 2025, then advanced by 0.66% to $32.6 million in 2026.
• Per Business Quant, the three latest SGMT Shares Outstanding (Entity) figures stand at $32.6 million (Q1 2026), $32.3 million (Q4 2025), and $32.5 million (Q3 2025).